The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: The great exploration

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Hutcheson, Rebecca ^a   Rocic, Petra ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT;

ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; ENVIRONMENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; OXIDATIVE STRESS; POLLUTION; PRIORITY JOURNAL; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; ANIMAL; METABOLISM; MOUSE; RISK FACTOR;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; METFORMIN; MICE; OBESITY; OXIDATIVE STRESS; RISK FACTORS;

EID: 84864987356     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/271028     Document Type: Review

References (142)

1. Grundy S. M., Metabolic syndrome pandemic Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 4 629 636 (Pubitemid 351651324)
2. Wilson P. W. F., Kannel W. B., Silbershatz H., D'Agostino R. B., Clustering of metabolic factors and coronary heart disease Archives of Internal Medicine 1999 159 10 1104 1109 (Pubitemid 29230863)
3. Suzuki T., Hirata K., Elkind M. S. V., Jin Z., Rundek T., Miyake Y., Boden-Albala B., Di Tullio M. R., Sacco R., Homma S., Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan study (NOMAS) American Heart Journal 2008 156 2 405 410
4. Ford E. S., Giles W. H., Mokdad A. H., Increasing prevalence of the metabolic syndrome among U.S. adults Diabetes Care 2004 27 10 2444 2449 (Pubitemid 39281399)
5. Sookoian S., Pirola C. J., Genetics of the cardiometabolic syndrome: new insights and therapeutic implications Therapeutic Advances in Cardiovascular Disease 2007 1 1 37 47
6. Alberti K. G. M. M., Zimmet P., Shaw J., Metabolic syndromea new world-wide definition. A consensus statement from the International Diabetes Federation Diabetic Medicine 2006 23 5 469 480
7. rnlv J., Ingelsson E., Sundstrm J., Lind L., Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men Circulation 2010 121 2 230 236
8. Noda H., Iso H., Saito I., Konishi M., Inoue M., Tsugane S., The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study Hypertension Research 2009 32 4 289 298
9. Lassgue B., Griendling K. K., NADPH oxidases: functions and pathologies in the vasculature Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 4 653 661
10. Cavalca V., Veglia F., Squellerio I., Marenzi G., Minardi F., de Metrio M., Cighetti G., Boccotti L., Ravagnani P., Tremoli E., Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender European Journal of Clinical Investigation 2009 39 4 267 272
11. Azumi H., Inoue N., Ohashi Y., Terashima M., Mori T., Fujita H., Awano K., Kobayashi K., Maeda K., Hata K., Shinke T., Kobayashi S., Hirata K. I., Kawashima S., Itabe H., Hayashi Y., Imajoh-Ohmi S., Itoh H., Yokoyama M., Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 11 1838 1844 (Pubitemid 35315770)
12. Folli F., Corradi D., Fanti P., Davalli A., Paez A., Giaccari A., Perego C., Muscogiuri G., The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro-and macrovascular complications: avenues for a mechanistic-based therapeutic approach Current Diabetes Reviews 2011 7 5 313 324
13. Fortuo A., San José G., Moreno M. U., Beloqui O., Dez J., Zalba G., Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome Diabetes 2006 55 1 209 215 (Pubitemid 43343317)
14. Hansel B., Giral P., Nobecourt E., Chantepie S., Bruckert E., Chapman M. J., Kontush A., Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity Journal of Clinical Endocrinology and Metabolism 2004 89 10 4963 4971 (Pubitemid 39391435)
15. Roberts C. K., Barnard R. J., Sindhu R. K., Jurczak M., Ehdaie A., Vaziri N. D., Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome Metabolism 2006 55 7 928 934 (Pubitemid 43902895)
16. Ford E. S., Mokdad A. H., Giles W. H., Brown D. W., The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey Diabetes 2003 52 9 2346 2352 (Pubitemid 37059506)
17. Perticone F., Ceravolo R., Candigliota M., Ventura G., Iacopino S., Sinopoli F., Mattioli P. L., Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C Diabetes 2001 50 1 159 165 (Pubitemid 32047995)
18. Montero D., Walther G., Perez-Martin A., Roche E., Vinet A., Endothelial dysfunction, inflammation, and oxidative stress in obese children and adolescents: markers and effect of lifestyle intervention Obesity Reviews 2012 13 5 441 455
19. Rector R. S., Warner S. O., Liu Y., Hinton P. S., Sun G. Y., Cox R. H., Stump C. S., Laughlin M. H., Dellsperger K. C., Thomas T. R., Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome American Journal of Physiology 2007 293 2 E500 E506
20. Roberts C. K., Won D., Pruthi S., Kurtovic S., Sindhu R. K., Vaziri N. D., Barnard R. J., Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors Journal of Applied Physiology 2006 100 5 1657 1665
21. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I., Increased oxidative stress in obesity and its impact on metabolic syndrome Journal of Clinical Investigation 2004 114 12 1752 1761 (Pubitemid 40385531)
22. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 2006 440 7086 944 948
23. de Mattia G., Bravi M. C., Laurenti O., Moretti A., Cipriani R., Gatti A., Mandosi E., Morano S., Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications Diabetes Research and Clinical Practice 2008 79 2 337 342
24. de Oliveira J., Hort M. A., Moreira E. L. G., Glaser V., Ribeiro-do-Valle R. M., Prediger R. D., Farina M., Latini A., de Bem A. F., Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress Neuroscience 2011 197 99 106
25. Marques de Mattos A., Marino L. V., Ovidio P. P., Jordo A. A., Almeida C. C., Chiarello P. G., Protein oxidative stress and dyslipidemia in dialysis patients Therapeutic Apheresis and Dialysis 2012 16 1 68 74
26. Zelzer S., Fuchs N., Almer G., Raggam R. B., Prller F., Truschnig-Wilders M., Schnedl W., Horejsi R., Mller R., Weghuber D., Ille R., Mangge H., High density lipoprotein cholesterol level is a robust predictor of lipid peroxidation irrespective of gender, age, obesity, and inflammatory or metabolic biomarkers Clinica Chimica Acta 2011 412 15-16 1345 1349
27. Andreadou I., Farmakis D., Prokovas E., Sigala F., Zoga A., Spyridaki K., Papalois A., Papapetropoulos A., Anastasiou-Nana M., Kremastinos D. T., Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress Cardiovascular Research 2012 94 3 501 509
28. Ansari J. A., Bhandari U., Pillai K. K., Haque S. E., Effect of rosuvastatin on obesity-induced cardiac oxidative stress in wistar ratsa preliminary study Indian Journal of Experimental Biology 2012 50 3 216 222
29. Ward N. C., Hodgson J. M., Puddey I. B., Mori T. A., Beilin L. J., Croft K. D., Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle Free Radical Biology and Medicine 2004 36 2 226 232 (Pubitemid 38117240)
30. Redn J., Oliva M. R., Tormos C., Giner V., Chaves J., Iradi A., Sez G. T., Antioxidant activities and oxidative stress byproducts in human hypertension Hypertension 2003 41 5 1096 1101 (Pubitemid 36548609)
31. Wang D., Strandgaard S., Iversen J., Wilcox C. S., Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension American Journal of Physiology 2009 296 2 R195 R200
32. Abdilla N., Tormo M. C., Fabia M. J., Chaves F. J., Saez G., Redon J., Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension Journal of Human Hypertension 2007 21 1 68 75 (Pubitemid 44921821)
33. Chen H. J., Pan W. H., Probable blind spot in the international diabetes federation definition of metabolic syndrome Obesity 2007 15 5 1096 1100
34. Monami M., Marchionni N., Masotti G., Mannucci E., IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients Diabetes, Obesity and Metabolism 2007 9 3 350 353 (Pubitemid 46502054)
35. Sanchez R., Fischer P., Cuniberti L., Masnatta L. D., Ramrez A. J., Vascular oxidative stress is associated with insulin resistance in hyper-reninemic nonmodulating essential hypertension Journal of Hypertension 2007 25 12 2434 2440 (Pubitemid 350064234)
36. Cottone S., Mul G., Nardi E., Vadal A., Lorito M. C., Guarneri M., Arsena R., Palermo A., Cerasola G., C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension Journal of Hypertension 2007 25 2 423 428 (Pubitemid 46071941)
37. Somers M. J., Mavromatis K., Galis Z. S., Harrison D. G., Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt Circulation 2000 101 14 1722 1728 (Pubitemid 30196634)
38. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., Holland S. M., Harrison D. G., Role of p47phox in vascular oxidative stress and hypertension caused by angiotensin II Hypertension 2002 40 4 511 515
39. Heitzer T., Wenzel U., Hink U., Krollner D., Skatchkov M., Stahl R. A. K., Macharzina R., Brsen J. H., Meinertz T., Mnzel T., Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C Kidney International 1999 55 1 252 260 (Pubitemid 29004257)
40. Rajagopalan S., Kurz S., Mnzel T., Tarpey M., Freeman B. A., Griendling K. K., Harrison D. G., Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone Journal of Clinical Investigation 1996 97 8 1916 1923
41. Freedman D. S., Dietz W. H., Srinivasan S. R., Berenson G. S., The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart study Pediatrics 1999 103 6 I 1175 1182 (Pubitemid 29258789)
42. Berenson G. S., Srinivasan S. R., Bao W., Newman W. P., Tracy R. E., Wattigney W. A., Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults The New England Journal of Medicine 1998 338 23 1650 1656 (Pubitemid 28267909)
43. Galili O., Versari D., Sattler K. J., Olson M. L., Mannheim D., McConnell J. P., Chade A. R., Lerman L. O., Lerman A., Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress American Journal of Physiology 2007 292 2 H904 H911
44. Kelly A. S., Steinberger J., Kaiser D. R., Olson T. P., Bank A. J., Dengel D. R., Oxidative stress and adverse adipokine profile characterize the metabolic syndrome in children Journal of the Cardiometabolic syndrome 2006 1 4 248 252
45. Ghio A. J., Carraway M. S., Madden M. C., Composition of air pollution particles and oxidative stress in cells, tissues, and living systems Journal of Toxicology and Environmental Health Part B 2012 15 1 1 21
46. Chuang K. J., Chan C. C., Su T. C., Lee C. T., Tang C. S., The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults American Journal of Respiratory and Critical Care Medicine 2007 176 4 370 376
47. Mills N. L., Donaldson K., Hadoke P. W., Boon N. A., MacNee W., Cassee F. R., Sandstrm T., Blomberg A., Newby D. E., Adverse cardiovascular effects of air pollution Nature Clinical Practice Cardiovascular Medicine 2009 6 1 36 44
48. Zanobetti A., Franklin M., Koutrakis P., Schwartz J., Fine particulate air pollution and its components in association with cause-specific emergency admissions Environmental Health 2009 8 1, article 58
49. Tonstad S., Svendsen M., Premature coronary heart disease, cigarette smoking, and the metabolic syndrome The American Journal of Cardiology 2005 96 12 1681 1685 (Pubitemid 41790391)
50. Chen C. C., Li T. C., Chang P. C., Liu C. S., Lin W. Y., Wu M. T., Li C. I., Lai M. M., Lin C. C., Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan Metabolism 2008 57 4 544 548
51. Nakatani D., Sakata Y., Sato H., Mizuno H., Shimizu M., Suna S., Ito H., Koretsune Y., Hirayama A., Hori M., Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction The American Journal of Cardiology 2007 99 7 885 889 (Pubitemid 46483273)
52. Zhang J., Jiang S., Watson R. R., Antioxidant supplementation prevents oxidation and inflammatory responses induced by sidestream cigarette smoke in old mice Environmental Health Perspectives 2001 109 10 1007 1009 (Pubitemid 33100405)
53. Chen H., Goldberg M. S., Viileneuve P. J., A systematic review of the relation between long-term exposure to ambient air pollution and chronic diseases Reviews on Environmental Health 2008 23 4 243 297
54. Henrotin J. B., Zeller M., Lorgis L., Cottin Y., Giroud M., Béjot Y., Evidence of the role of short-term exposure to ozone on ischaemic cerebral and cardiac events: the Dijon Vascular project (DIVA) Heart 2010 96 24 1990 1996
55. Mustafi H., Jabre P., Caussin C., Murad M. H., Escolano S., Tafflet M., Périer M.-C., Marijon E., Vernerey D., Empana J.-P., Jouven X., Main air pollutants and myocardial infarction: a systematic review and meta-analysis The Journal of the American Medical Association 2012 307 7 713 721
56. Brook R. D., Rajagopalan S., Pope C. A., Brook J. R., Bhatnagar A., Diez-Roux A. V., Holguin F., Hong Y., Luepker R. V., Mittleman M. A., Peters A., Siscovick D., Smith S. C., Whitsel L., Kaufman J. D., Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the american heart association Circulation 2010 121 21 2331 2378
57. Pereira Filho M. A., Pereira L. A. A., Arbex F. F., Arbex M., Conceio G. M., Santos U. P., Lopes A. C., Saldiva P. H. N., Braga A. L. F., Cendon S., Effect of air pollution on diabetes and cardiovascular diseases in So Paulo, Brazil Brazilian Journal of Medical and Biological Research 2008 41 6 526 532
58. Bateson T. F., Schwartz J., Who is sensitive to the effects of particulate air pollution on mortality? A case-crossover analysis of effect modifiers Epidemiology 2004 15 2 143 149 (Pubitemid 40416967)
59. Park S. K., Auchincloss A. H., O'Neill M. S., Prineas R., Correa J. C., Keeler J., Graham Barr R., Kaufman J. D., Roux A. V. D., Particulate air pollution, metabolic syndrome, and heart rate variability: the multi-ethnic study of atherosclerosis (MESA) Environmental Health Perspectives 2010 118 10 1406 1411
60. Cotrim H. P., Carvalho F., Siqueira A. C., Lordelo M., Rocha R., de Freitas L. A. R., Nonalcoholic fatty liver and insulin resistance among petrochemical workers The Journal of the American Medical Association 2005 294 13 1618 1620 (Pubitemid 41407353)
61. Sirit Y., Acero C., Bellorin M., Portillo R., Metabolic syndrome and other factors cardiovascular risk in workers of a plant of vinyl polychloride Revista de Salud Publica 2008 10 2 239 249
62. Mohan V., Deepa M., Farooq S., Prabhakaran D., Reddy K. S., Surveillance for risk factors of cardiovascular disease among an industrial population in Southern India National Medical Journal of India 2008 21 1 8 13 (Pubitemid 351420140)
63. Lang I. A., Galloway T. S., Scarlett A., Henley W. E., Depledge M., Wallace R. B., Melzer D., Association of Urinary Bisphenol A concentration with medical disorders and laboratory abnormalities in adults The Journal of the American Medical Association 2008 300 11 1303 1310
64. Sakurai K., Kawazuma M., Adachi T., Harigaya T., Saito Y., Hashimoto N., Mori C., Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes British Journal of Pharmacology 2004 141 2 209 214 (Pubitemid 38250890)
65. Prozialeck W. C., Edwards J. R., Nebert D. W., Woods J. M., Barchowsky A., Atchison W. D., The vascular system as a target of metal toxicity Toxicological Sciences 2008 102 2 207 218 (Pubitemid 351404893)
66. Wang S. L., Chiou J. M., Chen C. J., Tseng C. H., Chou W. L., Wang C. C., Wu T. N., Chang L. W., Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in Southwestern arseniasis-endemic and nonendemic areas in Taiwan Environmental Health Perspectives 2003 111 2 155 159 (Pubitemid 36305311)
67. Rahman M., Tondel M., Ahmad S. A., Axelson O., Diabetes mellitus associated with arsenic exposure in Bangladesh American Journal of Epidemiology 1998 148 2 198 203 (Pubitemid 28334897)
68. Afridi H. I., Kazi T. G., Kazi N., Jamali M. K., Arain M. B., Jalbani N., Baig J. A., Sarfraz R. A., Evaluation of status of toxic metals in biological samples of diabetes mellitus patients Diabetes Research and Clinical Practice 2008 80 2 280 288
69. Navas-Acien A., Silbergeld E. K., Pastor-Barriuso R., Guallar E., Arsenic exposure and prevalence of type 2 diabetes in US adults The Journal of the American Medical Association 2008 300 7 814 822
70. Paul D. S., Harmon A. W., Devesa V., Thomas D. J., Stblo M., Molecular mechanisms of the diabetogenic effects of arsenic inhibition of insulin signaling by arsenite and methylarsonous acid Environmental Health Perspectives 2007 115 5 734 742 (Pubitemid 46785043)
71. Sun Q., Yue P., Deiuliis J. A., Lumeng C. N., Kampfrath T., Mikolaj M. B., Cai Y., Ostrowski M. C., Lu B., Parthasarathy S., Brook R. D., Moffatt-Bruce S. D., Chen L. C., Rajagopalan S., Ambient air pollution exaggerates adipose inflammation and insulin resistance in a mouse model of diet-induced obesity Circulation 2009 119 4 538 546
72. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., D'Armiento M., D'Andrea F., Giugliano D., Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial The Journal of the American Medical Association 2004 292 12 1440 1446 (Pubitemid 39258336)
73. Cottone S., Mul G., Nardi E., Vadal A., Guarneri M., Briolotta C., Arsena R., Palermo A., Riccobene R., Cerasola G., Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension American Journal of Hypertension 2006 19 3 313 318 (Pubitemid 43261515)
74. Abramson J. L., Hooper W. C., Jones D. P., Ashfaq S., Rhodes S. D., Weintraub W. S., Harrison D. G., Quyyumi A. A., Vaccarino V., Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease Atherosclerosis 2005 178 1 115 121 (Pubitemid 39600823)
75. Fit M., Cladellas M., de la Torre R., Mart J., Alcntara M., Pujadas-Bastardes M., Marrugat J., Bruguera J., Lpez-Sabater M. C., Vila J., Covas M. I., Schrder H., Weinbrenner T., Muoz D., Farré M., Menoyo E., Mir-Casas E., Closas N., de la Torre-Boronat C., Gimeno E., Lamuela R., Lpez M. C., Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial Atherosclerosis 2005 181 1 149 158 (Pubitemid 40804706)
76. John J. H., Ziebland S., Yudkin P., Roe L. S., Neil H. A. W., Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial The Lancet 2002 359 9322 1969 1974 (Pubitemid 34663710)
77. Basu A., Sanchez K., Leyva M. J., Wu M., Betts N. M., Aston C. E., Lyons T. J., Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome Journal of the American College of Nutrition 2010 29 1 31 40
78. Stancliffe R. A., Thorpe T., Zemel M. B., Dairy attentuates oxidative and inflammatory stress in metabolic syndrome The American Journal of Clinical Nutrition 2011 94 2 422 430
79. Antonini-Canterin F., la Carrubba S., Gullace G., Zito C., Di Bello V., Di Salvo G., Benedetto F., Novo S., Pezzano A., Perticone F., Balbarini A., Carerj S., Association between carotid atherosclerosis and metabolic syndrome: results from the ISMIR study Angiology 2010 61 5 443 448
80. Kawamoto R., Tomita H., Ohtsuka N., Inoue A., Kamitani A., Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness Journal of Atherosclerosis and Thrombosis 2007 14 2 78 85
81. Iglseder B., Cip P., Malaimare L., Ladurner G., Paulweber B., The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men Stroke 2005 36 6 1212 1217 (Pubitemid 40798741)
82. Kip K. E., Marroquin O. C., Kelley D. E., Johnson B. D., Kelsey S. F., Shaw L. J., Rogers W. J., Reis S. E., Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the women's ischemia syndrome evaluation (WISE) study Circulation 2004 109 6 706 713 (Pubitemid 38222888)
83. Roger V. L., Go A. S., Lloyd-Jones D. M., Adams R. J., Berry J. D., Brown T. M., Carnethon M. R., Dai S., de Simone G., Ford E. S., Heart disease and stroke statistics2011 update: a report from the American Heart Association Circulation 2011 123 e18 e209
84. Kim J. Y., Mun H. S., Lee B. K., Yoon S. B., Choi E. Y., Min P. K., Yoon Y. W., Hong B. K., Rim S. J., Kwon H. M., Impact of metabolic syndrome and its individual components on the presence and severity of angiographic coronary artery disease Yonsei Medical Journal 2010 51 5 676 682
85. Schernthaner G., Cardiovascular mortality and morbidity in type-2 diabetes mellitus Diabetes Research and Clinical Practice 1996 31 S3 S13
86. Lakka H. M., Laaksonen D. E., Lakka T. A., Niskanen L. K., Kumpusalo E., Tuomilehto J., Salonen J. T., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men The Journal of the American Medical Association 2002 288 21 2709 2716 (Pubitemid 35403784)
87. Kotur-Stevuljevic J., Memon L., Stefanovic A., Spasic S., Spasojevic-Kalimanovska V., Bogavac-Stanojevic N., Kalimanovska-Ostric D., Jeli-Ivanovic Z., Zunic G., Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients Clinical Biochemistry 2007 40 3-4 181 187 (Pubitemid 46111070)
88. Meisinger C., Baumert J., Khuseyinova N., Loewel H., Koenig W., Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population Circulation 2005 112 5 651 657 (Pubitemid 41099043)
89. Kajimoto K., Kasai T., Miyauchi K., Hirose H., Yanagisawa N., Yamamoto T., Takazawa K., Niinami H., Hosoda Y., Daida H., Amano A., Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery Circulation Journal 2008 72 9 1481 1486
90. Brackbill M. L., Sytsma C. S., Sykes K., Perioperative outcomes of coronary artery bypass grafting: effects of metabolic syndrome and patient's sex American Journal of Critical Care 2009 18 5 468 473
91. Hoffmann R., Stellbrink E., Schrder J., Grawe A., Vogel G., Blindt R., Kelm M., Radke P. W., Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents The American Journal of Cardiology 2007 100 9 1347 1352 (Pubitemid 47576009)
92. Yaginuma K., Kasai T., Miyauchi K., Kajimoto K., Amano A., Daida H., Propensity score analysis of 10-year long-term outcome after bypass surgery or plain old balloon angioplasty in patients with metabolic syndrome International Heart Journal 2011 52 6 372 376
93. Marso S. P., Murphy J. W., House J. A., Safley D. M., Harris W. S., Metabolic syndrome-mediated inflammation following elective percutaneous coronary intervention Diabetes and Vascular Disease Research 2005 2 1 31 36 (Pubitemid 40333202)
94. Almalla M., Schrder J., Deserno V., Vogt F., Koos R., Koch K. C., Marx N., Hoffmann R., Long-term clinical outcome of sirolimus-eluting stent implantation in metabolic syndrome and diabetes Journal of Invasive Cardiology 2010 22 7 317 321
95. Hu R., Ma C. S., Nie S. P., L Q., Kang J. P., Du X., Zhang Y., Gao Y. C., He L. Q., Jia C. Q., Liu X. M., Dong J. Z., Liu X. H., Chen F., Zhou Y. J., L S. Z., Wu X. S., Effect of metabolic syndrome on prognosis and clinical characteristics of revascularization in patients with coronary artery disease Chinese Medical Journal 2006 119 22 1871 1876 (Pubitemid 44816864)
96. Onishi T., Shimada K., Sunayama S., Ohmura H., Sumide T., Masaki Y., Fukao K., Nishitani M., Kume A., Sato H., Naito H., Kawai S., Amano A., Daida H., Effects of cardiac rehabilitation in patients with metabolic syndrome after coronary artery bypass grafting Journal of Cardiology 2009 53 3 381 387
97. Sung S. H., Wu T. C., Huang C. H., Lin S. J., Chen J. W., Prognostic impact of body mass index in patients undergoing coronary artery bypass surgery Heart 2011 97 8 648 654
98. Foody J. A. M., Ferdinand F. D., Pearce G. L., Lytle B. W., Cosgrove D. M., Sprecher D. L., HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from the Cleveland Clinic Foundation Circulation 2000 102 19 III-90 III-94
99. Yun J., Rocic P., Pung Y. F., Belmadani S., Carrao A. C. R., Ohanyan V., Chilian W. M., Redox-dependent mechanisms in coronary collateral growth: the redox window hypothesis Antioxidants and Redox Signaling 2009 11 8 1961 1974
100. Yilmaz M. B., Caldir V., Guray Y., Guray U., Altay H., Demirkan B., Cay S., Kisacik H. L., Korkmaz S., Relation of coronary collateral vessel development in patients with a totally occluded right coronary artery to the metabolic syndrome The American Journal of Cardiology 2006 97 5 636 639 (Pubitemid 43255030)
101. Sasmaz H., Yilmaz M. B., Coronary collaterals in obese patients: impact of metabolic syndrome Angiology 2009 60 2 164 168
102. Mouquet F., Cuilleret F., Susen S., Sautire K., Marboeuf P., Ennezat P. V., McFadden E., Pigny P., Richard F., Hennache B., Vantyghem M. C., Bertrand M., Dallongeville J., Jude B., Van Belle E., Metabolic syndrome and collateral vessel formation in patients with documented occluded coronary arteries: association with hyperglycaemia, insulin-resistance, adiponectin and plasminogen activator inhibitor-1 European Heart Journal 2009 30 7 840 849
103. Reed R., Kolz C., Potter B., Rocic P., The mechanistic basis for the disparate effects of angiotensin II on coronary collateral growth Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 1 61 67
104. Hattan N., Chilian W. M., Park F., Rocic P., Restoration of coronary collateral growth in the zucker obese rat: impact of VEGF and ecSOD Basic Research in Cardiology 2007 102 3 217 223 (Pubitemid 46564070)
105. Weihrauch D., Lohr N. L., Mraovic B., Ludwig L. M., Chilian W. M., Pagel P. S., Warltier D. C., Kersten J. R., Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin Circulation 2004 109 19 2343 2348 (Pubitemid 38656871)
106. Lassaletta A. D., Chu L. M., Robich M. P., Elmadhun N. Y., Feng J., Burgess T. A., Laham R. J., Sturek M., Sellke F. W., Overfed Ossabaw swine with early stage metabolic syndrome have normal coronary collateral development in response to chronic ischemia Basic Research in Cardiology 2012 107 2, article 243
107. Mohri M., Tomoike H., Noma M., Inoue T., Hisano K., Nakamura M., Duration of ischemia is vital for collateral development: repeated brief coronary artery occlusion in conscious dogs Circulation Research 1989 64 2 287 296 (Pubitemid 19054025)
108. Yamanishi K., Fujita M., Ohno A., Sasayama S., Importance of myocardial ischemia for recruitment of coronary collateral circulation in dogs Cardiovascular Research 1990 24 4 271 277 (Pubitemid 20140933)
109. Rocic P., Kolz C., Reed R., Potter B., Chilian W. M., Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth American Journal of Physiology 2007 292 6 H2729 H2736
110. Pung Y. F., Rocic P., Murphy M. P., Smith R. A. J., Hafemeister J., Ohanyan V., Guarini G., Yin L., Chilian W. M., Resolution of mitochondrial oxidative stress rescues coronary collateral growth in zucker obese fatty rats Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 2 325 334
111. Reed R., Potter B., Smith E., Jadhav R., Villalta P., Jo H., Rocic P., Redox-sensitive Akt and Src regulate coronary collateral growth in metabolic syndrome American Journal of Physiology 2009 296 6 H1811 H1821
112. Miller S. J., Coppinger B. J., Zhou X., Unthank J. L., Antioxidants reverse age-related collateral growth impairment Journal of Vascular Research 2010 47 2 108 114
113. Lonn E., Bosch J., Yusuf S., Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial The Journal of the American Medical Association 2005 293 11 1338 1347 (Pubitemid 40381486)
114. Knekt P., Ritz J., Pereira M. A., O'Reilly E. J., Augustsson K., Fraser G. E., Goldbourt U., Heitmann B. L., Hallmans G., Liu S., Pietinen P., Spiegelman D., Stevens J., Virtamo J., Willett W. C., Rimm E. B., Ascherio A., Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts The American Journal of Clinical Nutrition 2004 80 6 1508 1520 (Pubitemid 41103847)
115. Halliwell B., The antioxidant paradox The Lancet 2000 355 9210 1179 1180 (Pubitemid 30172947)
116. Meagher E. A., Barry O. P., Lawson J. A., Rokach J., FitzGerald G. A., Effects of vitamin E on lipid peroxidation in healthy persons The Journal of the American Medical Association 2001 285 9 1178 1182 (Pubitemid 32198483)
117. Czernichow S., Vergnaud A. C., Galan P., Arnaud J., Favier A., Faure H., Huxley R., Hercberg S., Ahluwalia N., Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults The American Journal of Clinical Nutrition 2009 90 2 329 335
118. Demircan N., Grel A., Armutcu F., nalacak M., Aktun E., Atmaca H., The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome Medical Science Monitor 2008 14 2 CR97 CR101
119. Beydoun M. A., Shroff M. R., Chen X., Beydoun H. A., Wang Y., Zonderman A. B., Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys Journal of Nutrition 2011 141 5 903 913
120. Cangemi R., Angelico F., Loffredo L., Del Ben M., Pignatelli P., Martini A., Violi F., Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: effect of ascorbic acid Free Radical Biology and Medicine 2007 43 5 853 859 (Pubitemid 47102131)
121. Basu A., Betts N. M., Ortiz J., Simmons B., Wu M., Lyons T. J., Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome Nutrition Research 2011 31 3 190 196
122. Upston J. M., Terentis A. C., Morris K., Keaney J. F. Jr., Stocker R., Oxidized lipid accumulates in the presence of -tocopherol in atherosclerosis Biochemical Journal 2002 363 3 753 760 (Pubitemid 34526396)
123. Seon Hwa Lee, Oe T., Blair I. A., Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins Science 2001 292 5524 2083 2086 (Pubitemid 32691576)
124. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M. S., Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial The Lancet 2000 356 9237 1213 1218
125. Heinecke J. W., Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress Free Radical Biology and Medicine 2002 32 11 1090 1101 (Pubitemid 34603347)
126. Hou X., Song J., Li X. N., Zhang L., Wang X., Chen L., Shen Y. H., Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway Biochemical and Biophysical Research Communications 2010 396 2 199 205
127. Bellin C., de Wiza D. H., Wiernsperger N. F., Rsen P., Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin Hormone and Metabolic Research 2006 38 11 732 739 (Pubitemid 44885426)
128. Alhaider A. A., Korashy H. M., Sayed-Ahmed M. M., Mobark M., Kfoury H., Mansour M. A., Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression Chemico-Biological Interactions 2011 192 3 233 242
129. Meaney E., Vela A., Samaniego V., Meaney A., Asbn J., Zempoalteca J. C., Elisa Z. N., Emma M. N., Guzman M., Hicks J., Ceballos G., Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study Clinical and Experimental Pharmacology and Physiology 2008 35 8 895 903 (Pubitemid 351951937)
130. Yusuf S., Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The New England Journal of Medicine 2000 342 3 145 153 (Pubitemid 30051645)
131. Kovesdy C., Bangalore S., Imai E., Esquivel E., Telmisartan, Ramipril, or both in patients at high risk for vascular events. Commentary from F1000 The New England Journal of Medicine 2008 358 1547 1559
132. Harrison D. G., Cai H., Landmesser U., Griendling K. K., The Pickering Lecture British Hypertension Society, 10th September 2002: interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease Journal of the Renin-Angiotensin-Aldosterone System 2003 4 2 51 61
133. Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W., Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circulation Research 1994 74 6 1141 1148 (Pubitemid 24176909)
134. Cingolani O. H., Pérez N. G., Ennis I. L., lvarez M. C., Mosca S. M., Schinella G. R., Escudero E. M., Cnsole G., Cingolani H. E., In vivo key role of reactive oxygen species and NHE-1 activation in determining excessive cardiac hypertrophy Pflgers Archiv European Journal of Physiology 2011 462 5 733 743
135. Khan B. V., Sola S., Lauten W. B., Natarajan R., Hooper W. C., Menon R. G., Lerakis S., Helmy T., Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome Diabetes Care 2004 27 7 1712 1715 (Pubitemid 38857449)
136. Yoshida J., Yamamoto K., Mano T., Sakata Y., Nishikawa N., Nishio M., Ohtani T., Miwa T., Hori M., Masuyama T., AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure Hypertension 2004 43 3 686 691 (Pubitemid 38282448)
137. Henriksen E. J., Improvement of insulin sensitivity by antagonism of the renin-angiotensin system American Journal of Physiology 2007 293 3 R974 R980
138. Henriksen E. J., Jacob S., Kinnick T. R., Teachey M. K., Krekler M., Selective angiotensin II receptor antagonism reduces insulin resistance in obese zucker rats Hypertension 2001 38 4 884 890 (Pubitemid 34258687)
139. Oltman C. L., Kleinschmidt T. L., Davidson E. P., Coppey L. J., Lund D. D., Yorek M. A., Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes Vascular Pharmacology 2008 48 1 47 53
140. Al-Thanoon Z. A., Mahmood I. H., Effects of losartan vs. enalapril on the markers of metabolic syndrome Oman Medical Journal 2012 27 1 27 30
141. Csibi A., Communi D., Mller N., Bottari S. P., Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms PLoS ONE 2010 5 4
142. Wei Y., Sowers J. R., Nistala R., Gong H., Uptergrove G. M. E., Clark S. E., Morris E. M., Szary N., Manrique C., Stump C. S., Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells The Journal of Biological Chemistry 2006 281 46 35137 35146 (Pubitemid 46036553)